OTCBB:AGNPF

Algernon Pharmaceuticals Stock Forecast

etoro logo Buy AGNPF
*Your capital is at risk
$0.341
+0.0212 (+6.63%)
At Close: Jun 05, 2026
Add AGNPF to Watchlist?
  • Easy Tracking In The Watchlist

AGNPF Performance

FAQ

What is the symbol for Algernon Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Algernon Pharmaceuticals Inc. is AGNPF and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Algernon Pharmaceuticals Inc. Stock?
Algernon Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Algernon Pharmaceuticals Inc. Stock?
Algernon Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Algernon Pharmaceuticals Inc. Stock.

What's the current price of Algernon Pharmaceuticals Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Algernon Pharmaceuticals Inc. (AGNPF) share was $0.341.

What is the 52-week high and low for Algernon Pharmaceuticals Inc. Stock?
The 52-week high for Algernon Pharmaceuticals Inc. Stock is $0.713 and the 52-week low is $0.0357.

What is the market capitalization of Algernon Pharmaceuticals Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Algernon Pharmaceuticals Inc. is 1.194M.

When is the next earnings date for Algernon Pharmaceuticals Inc.?
The upcoming earnings date for Algernon Pharmaceuticals Inc. is Jul 24, 2026.
Click to get the best stock tips daily for free!
ABOUT ALGERNON PHARMACEUTICALS INC.
Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets N...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE